Plasma Oxytocin as a Superior Preoperative Biomarker for Predicting Transient Postoperative Arginine Vasopressin Deficiency Following Transsphenoidal Pituitary Surgery

Plasma Oxytocin as a Superior Preoperative Biomarker for Predicting Transient Postoperative Arginine Vasopressin Deficiency Following Transsphenoidal Pituitary Surgery

This study identifies plasma oxytocin as a superior preoperative biomarker compared to copeptin for early prediction of transient arginine vasopressin deficiency after transsphenoidal pituitary surgery, aiding in risk stratification and postoperative management.
Longitudinal Changes in Cortisol Secretion and Cardiometabolic Outcomes in Benign Adrenal Incidentalomas: Insights from a Large Retrospective Cohort

Longitudinal Changes in Cortisol Secretion and Cardiometabolic Outcomes in Benign Adrenal Incidentalomas: Insights from a Large Retrospective Cohort

This study examines how temporal cortisol secretion changes in benign adrenal incidentalomas relate to long-term cardiometabolic outcomes and mortality, highlighting the significance of persistent mild autonomous cortisol secretion for hypertension management.
Long-term Outcomes of Oral Decitabine/Cedazuridine Plus Venetoclax in Older or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia

Long-term Outcomes of Oral Decitabine/Cedazuridine Plus Venetoclax in Older or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia

Oral decitabine/cedazuridine plus venetoclax provides an effective, fully oral frontline therapy for older or unfit patients with AML, showing encouraging response rates and manageable safety with long-term follow-up, highlighting particular challenges in secondary AML.